Louisiana State Employees Retirement System Uni Qure N.V. Transaction History

Louisiana State Employees Retirement System

$5.33 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$11.12 - $22.2 $31,135 - $62,160	2,800 Added 14.58%	22,000 $252,000
Q1 2023 Apr 19, 2023	SELL	$18.7 - $23.07 $7,480 - $9,228	-400 Reduced 2.04%	19,200 $386,000
Q3 2022 Oct 19, 2022	BUY	$16.98 - $25.54 $33,960 - $51,080	2,000 Added 11.36%	19,600 $368,000
Q2 2022 Jul 20, 2022	BUY	$13.15 - $20.45 $1,315 - $2,045	100 Added 0.57%	17,600 $424,000
Q1 2022 Apr 22, 2022	BUY	$14.54 - $21.5 $1,454 - $2,150	100 Added 0.57%	17,500 $305,000
Q4 2021 Jan 14, 2022	BUY	$20.24 - $36.01 $2,023 - $3,601	100 Added 0.58%	17,400 $361,000
Q3 2021 Oct 12, 2021	BUY	$26.01 - $38.22 $449,973 - $661,206	17,300 New	17,300 $554,000

Others Institutions Holding QURE

# of Institutions

142

Shares Held

35.3M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Account